ARTICLE SUMMARY:
The organizations inked an agreement including industry-first performance-based rebates.
Medtronic plc and Minnesota’s largest health plan, Blue Cross and Blue Shield of Minnesota (BCBSMN), are working together in a first-of-its-kind, outcomes-based agreement in which Medtronic will pay patients using its new Guardian Connect smart Continuous Glucose Monitoring (CGM) system who don't see their blood sugar levels stay within an acceptable range. With this incentive-based agreement, and other partnerships—including a recent performance guarantee tied to its MiniMed 670G self-adjusting insulin pump—Medtronic is putting its money where its mouth is in terms of containing costs, and improving health outcomes and quality of life for one of the world’s most costly chronic diseases: diabetes.
